raloxifene hydrochloride has been researched along with apomorphine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Gogos, A; van den Buuse, M | 1 |
| Gogos, A; Sbisa, A; van den Buuse, M | 1 |
| Bochar, DA; Deng, X; Dexheimer, T; Hovde, S; Kuo, MH; Kwok, R; Liu, M; Sui, D | 1 |
4 other study(ies) available for raloxifene hydrochloride and apomorphine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Topics: Acoustic Stimulation; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Ovariectomy; Prepulse Inhibition; Raloxifene Hydrochloride; Random Allocation; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle; Schizophrenia; Selective Estrogen Receptor Modulators; Tamoxifen | 2015 |
The effect of estrogenic compounds on psychosis-like behaviour in female rats.
Topics: Animals; Apomorphine; Dopamine Agonists; Estradiol; Estrogens; Female; Ovariectomy; Psychotic Disorders; Raloxifene Hydrochloride; Rats; Rats, Long-Evans; Receptors, Dopamine; Schizophrenia; Selective Estrogen Receptor Modulators; Tamoxifen | 2018 |
Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
Topics: Alzheimer Disease; Apomorphine; Benzodiazepines; Cognition; Drug Discovery; Drug Evaluation, Preclinical; Humans; Phosphorylation; Prescription Drugs; Protein Aggregates; Raloxifene Hydrochloride; Risk Factors; tau Proteins | 2020 |